Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: No

Multiple Sclerosis Journal 2026 Open access

Read full text

Authors: Niels Hellings

DOI: 10.1177/13524585251409970

Cited by: 0

References: 10

Abstract

Funding The author received no financial support for the research, authorship, and/or publication of this article.

Multiple Sclerosis Research Studies Viral-associated cancers and disorders Cytomegalovirus and herpesvirus research

References 10